findmyKOL
Clinical trialNCT05886036RecruitingPhase 2Interventional

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

SponsorNational Cancer Institute (NCI)Enrollment70Nodular Lymphocyte Predominant B-Cell LymphomaRecurrent Nodular Lymphocyte Predominant B-Cell LymphomaRefractory Nodular Lymphocyte Predominant B-Cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Raphael E Steiner

    University of Texas MD Anderson Cancer Center LAO

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University Health Network-Princess Margaret Hospital

    Toronto, Ontario, Canada

    Anca Prica
    Recruiting
United States
  • City of Hope Comprehensive Cancer Center

    Duarte, California, United States

    Alex F. Herrera
    Recruiting
  • Um Sylvester Comprehensive Cancer Center at Aventura

    Aventura, Florida, United States

    Michele Stanchina
    Recruiting
  • Um Sylvester Comprehensive Cancer Center at Coral Gables

    Coral Gables, Florida, United States

    Michele Stanchina
    Recruiting
  • Um Sylvester Comprehensive Cancer Center at Coral Springs

    Coral Springs, Florida, United States

    Michele Stanchina
    Recruiting
  • Um Sylvester Comprehensive Cancer Center at Deerfield Beach

    Deerfield Beach, Florida, United States

    Michele Stanchina
    Recruiting
  • Um Sylvester Comprehensive Cancer Center at Doral

    Doral, Florida, United States

    Michele Stanchina
    Recruiting
  • Um Sylvester Comprehensive Cancer Center at Hollywood

    Hollywood, Florida, United States

    Michele Stanchina
    Recruiting
  • Um Sylvester Comprehensive Cancer Center at Kendall

    Miami, Florida, United States

    Michele Stanchina
    Recruiting
  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida, United States

    Michele Stanchina
    Recruiting
  • Um Sylvester Comprehensive Cancer Center at Plantation

    Plantation, Florida, United States

    Michele Stanchina
    Recruiting
  • Emory University Hospital/winship Cancer Institute

    Atlanta, Georgia, United States

    Pamela B. Allen
    Recruiting
  • University of Kansas Cancer Center

    Kansas City, Kansas, United States

    Marc S. Hoffmann
    Recruiting
  • University of Kansas Cancer Center-Overland Park

    Overland Park, Kansas, United States

    Marc S. Hoffmann
    Recruiting
  • University of Kansas Hospital-Westwood Cancer Center

    Westwood, Kansas, United States

    Marc S. Hoffmann
    Recruiting
  • University of Kansas Cancer Center - Briarcliff

    Kansas City, Missouri, United States

    Marc S. Hoffmann
    Recruiting
  • University of Kansas Cancer Center - North

    Kansas City, Missouri, United States

    Marc S. Hoffmann
    Recruiting
  • University of Kansas Cancer Center - Lee'S Summit

    Lee's Summit, Missouri, United States

    Marc S. Hoffmann
    Recruiting
  • University of Kansas Cancer Center at North Kansas City Hospital

    North Kansas City, Missouri, United States

    Suspended
  • Memorial Sloan Kettering Basking Ridge

    Basking Ridge, New Jersey, United States

    Raphael E. Steiner
    Recruiting
  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey, United States

    Raphael E. Steiner
    Recruiting
  • Memorial Sloan Kettering Bergen

    Montvale, New Jersey, United States

    Raphael E. Steiner
    Recruiting
  • Memorial Sloan Kettering Commack

    Commack, New York, United States

    Raphael E. Steiner
    Recruiting
  • Memorial Sloan Kettering Westchester

    Harrison, New York, United States

    Raphael E. Steiner
    Recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Raphael E. Steiner
    Recruiting
  • Memorial Sloan Kettering Nassau

    Uniondale, New York, United States

    Raphael E. Steiner
    Recruiting
  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, United States

    Rakhee Vaidya
    Recruiting
  • University of Cincinnati Cancer Center-Uc Medical Center

    Cincinnati, Ohio, United States

    Zulfa Omer
    Recruiting
  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

    Yun Choi
    Recruiting
  • University of Cincinnati Cancer Center-West Chester

    West Chester, Ohio, United States

    Zulfa Omer
    Recruiting
  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, United States

    Sami Ibrahimi
    Recruiting
  • University of Pittsburgh Cancer Institute (upci)

    Pittsburgh, Pennsylvania, United States

    Active, not recruiting
  • Ut Md Anderson Cancer Center

    Houston, Texas, United States

    Dai Chihara
    Recruiting
  • Huntsman Cancer Institute/university of Utah

    Salt Lake City, Utah, United States

    Allison Bock
    Recruiting
  • University of Virginia Cancer Center

    Charlottesville, Virginia, United States

    Nathan L. Roberts
    Recruiting
  • Vcu Massey Comprehensive Cancer Center

    Richmond, Virginia, United States

    Bruce O. Hough
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Jan 2024
Primary completion
31 Oct 2026
Completion
31 Oct 2026
Last update posted
9 Jul 2026
Registered enrollment
70
Registry id
NCT05886036

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.